Eligible patients in Northern Ireland are now being sought to take part in the trial
A major Cancer Research UK clinical trial aiming to find effective new treatments for patients with rare forms of the disease has launched in Belfast.
Principal Investigator Professor Vicky Coyle, of Queen’s University Belfast and the Belfast HSC Trust, said: "We are very excited that patients with rare cancers in Northern Ireland can now be offered targeted drugs as part of the DETERMINE clinical trial. Matching treatment to a specific patient is known as precision medicine, a growing area of cancer medicine. Precision medicine is particularly used in rare cancers or cancers with specific genetic faults which cause it to develop.
"We are delighted that in opening this precision medicine trial in Belfast, Cancer Research UK is supporting patients in Northern Ireland with more targeted therapies."
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Bono on a United Ireland: 'We haven’t fallen in love but we’re dating'Bono, said that joining together Northern Ireland with the Republic of Ireland would be “wonderful”
Consulte Mais informação »
New NI anonymity laws ‘would have prevented reporting of Savile allegations’The Society of Editors described new laws in Northern Ireland as an ‘affront to justice’.
Consulte Mais informação »
New NI anonymity laws ‘would have prevented reporting of Savile allegations’The Society of Editors described new laws in Northern Ireland as an ‘affront to justice’.
Consulte Mais informação »
'Benefits delay left my family short of food'A damning new report found one in five children in Northern Ireland now live in poverty
Consulte Mais informação »
Best pubs in Northern Ireland for 2024 named in Good Beer GuideThis year 17 pubs and 31 breweries have made the list
Consulte Mais informação »
Northern Ireland junior doctors to be balloted for industrial action“This is not a decision that has been taken lightly.”
Consulte Mais informação »